LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $200,000 | -32.7% | 2,325 | -10.6% | 0.00% | -100.0% |
| Q2 2019 | $297,000 | +12.9% | 2,602 | +24.4% | 0.00% | 0.0% |
| Q1 2019 | $263,000 | -25.9% | 2,091 | +61.6% | 0.00% | -50.0% |
| Q3 2018 | $355,000 | -1.7% | 1,294 | -25.7% | 0.00% | 0.0% |
| Q2 2018 | $361,000 | +57.6% | 1,742 | +25.9% | 0.00% | +100.0% |
| Q1 2018 | $229,000 | +11.2% | 1,384 | -19.7% | 0.00% | -50.0% |
| Q2 2016 | $206,000 | -78.3% | 1,724 | -84.4% | 0.00% | -87.5% |
| Q3 2015 | $949,000 | – | 11,083 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |